ImmunoGen (IMGN) Financials

$31.23

$0.00 (0.00%)

As on 13-Feb-2024 09:30EDT

Market cap

$8,724 Mln

Revenue (TTM)

$288 Mln

P/E Ratio

--

P/B Ratio

15.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	287.61	108.78	108.78	132.30	82.27	53.82
Cost of Revenue	3.87	0.18	0.18	114.59	114.52	173.89
Gross Profit	283.75	108.61	108.61	17.71	-32.25	-120.07
Operating Expenses	363.93	329.50	329.50	153.19	153.01	210.60
Operating Profit (EBIT)	-80.19	-220.89	-220.89	-135.49	-92.17	-160.48
Other Income	4.97	3.35	-1.08	1.21	5.01	3.33
Profit before Tax	-72.59	-221.71	-221.71	-44.37	-104.13	-167.87
Provision for Tax	0.48	1.22	1.22	22.31	17.96	7.39
Profit after Tax (Net Income)	-73.07	-222.93	-222.93	-66.68	-122.09	-167.87
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-73.52	-222.93	-139.30	-44.37	-104.13	-168.84

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	561.60	155.83	155.83	89.57	-76.12	11.94
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	125.85	71.25	71.25	143.18	234.37	213.75
Current Liabilities	134.66	121.86	121.86	122.32	77.41	70.06
Total Liabilities	956.76	348.94	348.94	355.07	235.66	295.75

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	85.87	73.80	73.80	61.22	59.44	33.50
Current Assets	736.23	275.14	275.14	293.86	176.23	262.25
Total Assets	956.76	348.94	348.94	355.07	235.66	295.75
Total Debt*	72.11	15.24	15.24	23.89	26.85	13.43
Net Current Assets	601.57	182.26	377.81	201.93	131.49	208.12

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-229.80	-229.80	-78.62	-88.37	-166.42
Cash Flow from Investing Activities	--	-1.36	-1.43	0.51	-0.53	-5.25
Cash from Financing Activities	--	27.55	27.55	195.74	2.87	166.81
Net Cash Inflow / Outflow	--	-203.61	184.89	117.63	-86.03	-4.86

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.30	-0.88	-1.03	-0.35	-0.82	-1.14
Cash EPS ($)	--	-0.87	-1.02	-0.34	-0.79	-1.09
Adjusted Book Value ($)	--	0.61	0.72	0.47	--	0.08
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.90	-1.06	-0.41	-0.59	-1.13
Free Cash Flow per Share ($)	--	-0.91	-1.07	-0.42	-0.61	-1.17

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-130.31	-156.70	-207.78	1,021.57	-1,856.18
ROE (%)	-21.38	-143.06	-181.69	-991.64	380.48	5,639.95
ROA (%)	-10.30	-63.89	-63.33	-22.58	-45.95	-56.86
EBIT Margin (%)	-27.37	-201.62	-203.06	-102.41	-112.04	-298.92
Net Margin (%)	-24.98	-198.81	-206.99	-49.95	-139.88	-293.75
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	200.83	--	-0.18	0.61	0.53	-0.53
EBIT Growth (%)	60.01	0.71	-63.04	-46.99	42.70	-161.32
Net Profit Growth (%)	64.12	--	-234.31	45.38	27.27	-74.85
EPS Growth (%)	64.08	0.15	-1.96	0.57	0.28	-0.48
Book Value Growth (%)	178.11	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-5.66	-7.18	-18.48	-6.22	-4.21
Price / Book Value	15.53	8.10	10.28	13.76	-9.98	59.20
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-134.36	-4.61	-6.17	-48.90	-9.29	-2.99
Close Price ($)	15.87	4.96	7.42	6.45	5.11	4.80
High Price ($)	20.69	7.69	10.88	7.87	6.13	13.41
Low Price ($)	3.61	3.10	4.73	1.95	1.76	3.80
Market Cap ($ Cr)	8,724.23	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.13	0.10	0.10	0.27	-0.35	1.12
Short term debt to equity ratio	0.04	0.03	0.03	0.06	-0.04	0.95
Current Ratio	5.47	2.26	2.26	2.40	2.28	3.74
Quick Ratio	5.43	2.50	2.12	2.65	2.70	3.98
Interest Coverage	-17.35	-52.66	-53.04	-5.84	-5.43	-15.00

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	45.44	16.53	16.53	17.00	33.12	22.42
Asset Turnover	0.41	0.31	0.31	0.45	0.31	0.18
Receivable days	--	60.36	67.95	68.67	87.27	58.69
Inventory Days	--	-13,268.33	-14,736.59	-100.52	-78.46	-16.27
Payable days	--	94,120.36	56,957.21	31.03	33.96	20.93
Cash Conversion Cycle	--	-107,328.32	-71,625.85	-62.88	-25.15	21.50

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.